News & Analysis on Clinical Trial Services & Contract Research And Development
With its manufacturing practices in Puerto Rico censured and marketing approval of its new oral contraceptive delayed because of its packaging, Wyeth has announced a plan to address its manufacturing issues but cautions there is no quick fix to its woes.
Indian custom chemical synthesis firm Denisco has opened up shop in the US to capitalise on the growing demand in North America for high-quality, low-cost complex organic molecules.
The US Food and Drug Administration (FDA) has turned down Nastech's generic version of the nasal spray Miacalcin for the treatment of osteoporosis because of the possibility of an interaction with a preservative used in the formulation, sparking...
A unique approach to drug development could be on the horizon after researchers utilised a method to crystallise proteins that would allow better examination of proteins, leading to the production of targeted drugs.
Galapagos and Cellzome have announced the start of a drug discovery collaboration in which the two companies are to concentrate on kinases, a popular target for pharmaceutical therapies for cancer and inflammatory diseases.
Agilent Technologies has introduced its new microarray that offers high-resolution genomic coverage, whilst enabling multiple experiments per slide. The technology has the potential to make savings both in time and cost.
There's welcome relief for haemorrhoid sufferers after researchers identified the existence of an enzyme that could be key to treating chronic and severe disorders such as certain forms of constipation, anal fissures and Hirschsprung's disease.
Labelling and packaging equipment company Advanced Dynamics has unveiled a new machine to label the outer packaging of pharmaceutical products in Braille, allowing companies to comply with EU regulations.
According to a new report the proteomic revolution and the emergence of the customised drug market has led to an increased demand for mass spectrometers in the US, driving strong growth over the next seven years.